Logo image of BRY.CA

BRI-CHEM CORP (BRY.CA) Stock Fundamental Analysis

TSX:BRY - Toronto Stock Exchange - CA10778T1057 - Common Stock - Currency: CAD

0.335  -0.01 (-1.47%)

Fundamental Rating

2

BRY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 13 industry peers in the Trading Companies & Distributors industry. The financial health of BRY is average, but there are quite some concerns on its profitability. BRY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BRY has reported negative net income.
In the past year BRY had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BRY reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: BRY reported negative operating cash flow in multiple years.
BRY.CA Yearly Net Income VS EBIT VS OCF VS FCFBRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

1.2 Ratios

With a Return On Assets value of -3.14%, BRY is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
BRY has a worse Return On Equity (-8.45%) than 84.62% of its industry peers.
BRY's Return On Invested Capital of 2.61% is on the low side compared to the rest of the industry. BRY is outperformed by 84.62% of its industry peers.
BRY had an Average Return On Invested Capital over the past 3 years of 6.80%. This is in line with the industry average of 7.89%.
The 3 year average ROIC (6.80%) for BRY is well above the current ROIC(2.61%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -3.14%
ROE -8.45%
ROIC 2.61%
ROA(3y)5.09%
ROA(5y)-2.46%
ROE(3y)17.85%
ROE(5y)-3.54%
ROIC(3y)6.8%
ROIC(5y)N/A
BRY.CA Yearly ROA, ROE, ROICBRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

BRY has a Operating Margin of 1.95%. This is amonst the worse of the industry: BRY underperforms 84.62% of its industry peers.
BRY's Gross Margin of 17.89% is on the low side compared to the rest of the industry. BRY is outperformed by 69.23% of its industry peers.
In the last couple of years the Gross Margin of BRY has grown nicely.
Industry RankSector Rank
OM 1.95%
PM (TTM) N/A
GM 17.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.03%
GM growth 5Y5.38%
BRY.CA Yearly Profit, Operating, Gross MarginsBRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRY is destroying value.
BRY has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRY has more shares outstanding
The debt/assets ratio for BRY has been reduced compared to a year ago.
BRY.CA Yearly Shares OutstandingBRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
BRY.CA Yearly Total Debt VS Total AssetsBRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that BRY is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.74, BRY is doing worse than 84.62% of the companies in the same industry.
BRY has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
BRY has a better Debt to FCF ratio (1.25) than 92.31% of its industry peers.
A Debt/Equity ratio of 1.03 is on the high side and indicates that BRY has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.03, BRY is doing worse than 76.92% of the companies in the same industry.
Although BRY does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 1.25
Altman-Z 1.74
ROIC/WACC0.3
WACC8.61%
BRY.CA Yearly LT Debt VS Equity VS FCFBRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

BRY has a Current Ratio of 1.48. This is a normal value and indicates that BRY is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.48, BRY is doing worse than 84.62% of the companies in the same industry.
BRY has a Quick Ratio of 1.48. This is a bad value and indicates that BRY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BRY (0.65) is worse than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 0.65
BRY.CA Yearly Current Assets VS Current LiabilitesBRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

0

3. Growth

3.1 Past

BRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -440.50%.
BRY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.65%.
The Revenue has been decreasing by -2.67% on average over the past years.
EPS 1Y (TTM)-440.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2%
Revenue 1Y (TTM)-15.65%
Revenue growth 3Y32.87%
Revenue growth 5Y-2.67%
Sales Q2Q%-18.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRY.CA Yearly Revenue VS EstimatesBRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
BRY.CA Yearly EPS VS EstimatesBRY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.1 0.2 0.3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRY.CA Price Earnings VS Forward Price EarningsBRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

BRY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BRY is cheaper than 69.23% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRY indicates a rather cheap valuation: BRY is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.49
EV/EBITDA 5.48
BRY.CA Per share dataBRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BRY!.
Industry RankSector Rank
Dividend Yield N/A

BRI-CHEM CORP

TSX:BRY (3/6/2025, 7:00:00 PM)

0.335

-0.01 (-1.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-11 2024-11-11
Earnings (Next)03-26 2025-03-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.8%
Ins Owner ChangeN/A
Market Cap8.85M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF 0.49
P/OCF 0.47
P/B 0.42
P/tB 0.42
EV/EBITDA 5.48
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.69
FCFY204.6%
OCF(TTM)0.71
OCFY211.57%
SpS3.38
BVpS0.8
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.14%
ROE -8.45%
ROCE 6.18%
ROIC 2.61%
ROICexc 2.61%
ROICexgc 2.61%
OM 1.95%
PM (TTM) N/A
GM 17.89%
FCFM 20.3%
ROA(3y)5.09%
ROA(5y)-2.46%
ROE(3y)17.85%
ROE(5y)-3.54%
ROIC(3y)6.8%
ROIC(5y)N/A
ROICexc(3y)6.8%
ROICexc(5y)N/A
ROICexgc(3y)6.8%
ROICexgc(5y)N/A
ROCE(3y)21.53%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.03%
GM growth 5Y5.38%
F-Score4
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 1.25
Debt/EBITDA 7.21
Cap/Depr 47.78%
Cap/Sales 0.69%
Interest Coverage 0.98
Cash Conversion 616.97%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 0.65
Altman-Z 1.74
F-Score4
WACC8.61%
ROIC/WACC0.3
Cap/Depr(3y)83.75%
Cap/Depr(5y)55.25%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-440.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.65%
Revenue growth 3Y32.87%
Revenue growth 5Y-2.67%
Sales Q2Q%-18.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y274.69%
FCF growth 3Y5.5%
FCF growth 5Y84.59%
OCF growth 1Y284.38%
OCF growth 3Y7.48%
OCF growth 5Y44.85%